X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

    Work Smart: Go for Hands-Free Lab Informatics at the Bench, Not Scribbled Notes and Delayed Documentation at Your Desk

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development

Rising Pharmaceuticals Demand Drives Tablet Coatings Market

Content Team by Content Team
13th May 2023
in Drug Development, News

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

The worldwide tablet coatings sector generated $2.2 billion in 2021 and is projected to reach $4.1 billion by 2031, growing at a CAGR of 6.6% from 2022 to 2031. Key takeaways include:

Increasing pharmaceutical demand: Growing global demand for pharmaceuticals drives the tablet coatings market as more people seek medical treatments and prescription drugs.

Technological advancements: Advancements in coating technologies enhance tablet manufacturing efficiency, improving the safety and efficacy of the final product.

Nutraceutical demand: The popularity of natural health supplements increases the demand for coated nutraceuticals with improved taste and odor.

Regulatory compliance: Tough quality benchmarks and regulatory requirements ensure the safety and efficacy of tablet coatings.

The market for global tablet coatings can be segmented based on the following:

Product type: Film coatings, sugar coatings, enteric coatings, and other specialty coatings.

Material: Polymers, cellulose derivatives, and other materials.

End-user: Pharmaceutical industry, nutraceutical industry, and others.

Application: Extended-release coatings, taste masking coatings, and others.

Region: North America, Asia Pacific, Europe, Latin America, and Africa the Middle East.

Sales channel: Direct sales and distributor sales.

Coating thickness: Thin and thick coatings.

North America dominates the tablet coatings market with the highest revenue share, driven by a strong healthcare infrastructure, high purchasing power, and widespread adoption of coated tablets. However, the Asia-Pacific region is expected to have the fastest growth rate, with a projected CAGR of 7.2% from 2022 to 2031. Factors contributing to this growth include a growing geriatric population and increased awareness of delayed-release tablet coatings.

Two notable trends in the market are the rising demand for enteric coatings, which protect active ingredients in the stomach and enable targeted delivery to the small intestine, and the increasing use of nanotechnology to develop thin and uniform coatings for enhanced API protection. Furthermore, there is a growing emphasis on eco-friendly coatings using biodegradable materials, reflecting consumer concerns about the environmental impact of traditional coatings.

Recent developments in the tablet coatings market include the following:

Rising demand for enteric coatings: Enteric coatings protect active ingredients, ensuring targeted delivery to the small intestine. This is driving demand in the pharmaceutical and nutraceutical industries.

Increasing use of nanotechnology: Nanotechnology enables the development of ultra-thin, uniform coatings, improving API protection and creating more efficient products.

Development of eco-friendly coatings: Companies are creating biodegradable coatings to address environmental concerns and meet consumer demand for sustainability.

Previous Post

Connected Drug Delivery Devices To Revolutionize Healthcare

Next Post

European Medicines Agency Ends COVID-19 Prioritization Plan

Related Posts

Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Emerging Oral Small Molecule Drugs
Drug Development

Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post

European Medicines Agency Ends COVID-19 Prioritization Plan

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In